Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.
Read more about After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and moreTag: Indian Patent Law
Searching for Patents and Patentability of AI and Software Inventions: Session 2 of the Masterclass on IP
This session of the masterclass explored patentability criteria and search strategies for AI and software inventions. Attendees learned about the patent process, prior art search, and practical considerations for Indian innovators. The session offered valuable guidance on intellectual property for startups.
Read more about Searching for Patents and Patentability of AI and Software Inventions: Session 2 of the Masterclass on IPIn Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies
The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis for compulsory licensing and argues for its strategic use to ensure public access to vaccines and medicines.
Read more about In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other TechnologiesIPO notifies Supreme Court’s latest decision on ‘Extension of Limitation’; Monsanto and Nuziveedu settle long standing patent dispute and more
This post examines the latest Supreme Court directions on limitation extension, the resolution of the Monsanto-Nuziveedu patent dispute, and ongoing developments at the EPO. It also discusses European parliamentary support for a temporary patent waiver proposed by India and South Africa.
Read more about IPO notifies Supreme Court’s latest decision on ‘Extension of Limitation’; Monsanto and Nuziveedu settle long standing patent dispute and moreIndian Patent Cases and Judgments of 2020
A detailed review of major Indian patent cases and judgments from 2020, addressing core issues in patent opposition, litigation, and enforcement. The analysis offers insights into judicial trends and key legal standards shaping Indian patent law.
Read more about Indian Patent Cases and Judgments of 2020HIGH COURT OF DELHI RULES GOVERNING PATENT SUITS, 2020
The Delhi High Court’s draft Rules Governing Patent Suits, 2020 propose a structured framework for patent litigation. These rules address procedural complexities, documentation, and expert involvement, ensuring clarity and efficiency in patent dispute resolution.
Read more about HIGH COURT OF DELHI RULES GOVERNING PATENT SUITS, 2020Patent (Amendment) Rules, 2020 come into force – Here are the changes
The Patents (Amendment) Rules, 2020 bring notable changes to Form 27 filing and priority document submission requirements in India. These amendments impact timelines and compliance obligations for patentees and applicants.
Read more about Patent (Amendment) Rules, 2020 come into force – Here are the changesCPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news
The CPI(M) has urged the Indian government to issue a compulsory license for Remdesivir to facilitate generic manufacturing. Additionally, the EPO has developed new patent search strategies for COVID-19, and an upcoming EUIPO-EPO conference will address intellectual property issues in additive manufacturing.
Read more about CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent newsPressing Need to Clear the Muddy Waters: SEP Litigation in India
This post examines the complexities of SEP litigation in India, focusing on the legal ambiguities around FRAND royalties and institutional approaches. It highlights the need for clear guidelines to ensure fair licensing and competition compliance in the Indian technology sector.
Read more about Pressing Need to Clear the Muddy Waters: SEP Litigation in IndiaCompulsory Licensing in India – Talk by Gaurav Mishra
Mr. Gaurav Mishra presented an in-depth session on compulsory licensing in India under the Patents Act at a DST Rajasthan event. The talk covered legal provisions, case studies, and the significance of compulsory licensing during the COVID-19 pandemic.
Read more about Compulsory Licensing in India – Talk by Gaurav Mishra